文献速递瓣膜病与结构性心脏病

乳糜心包炎的临床特征、评估与结局:一项系统综述

Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review.
PubMed 文献 · Heart · 2023-08-11

本研究系统检索1946年至2021年5月文献,纳入95篇文献共98例乳糜心包炎患者。患者平均年龄37±15岁,男性占55%,特发性占60%,心脏压塞占38%。63%接受内科治疗,32%进展至手术,随访中位180天复发率16%。结论认为该病多见于年轻患者,可致严重并发症,内科治疗失败需手术,总体死亡率低但并发症需密切随访。

要点

  • 乳糜心包炎多见于年轻患者,特发性占60%,心脏压塞发生率达38%。
  • 63%患者接受内科治疗,但32%最终需手术干预。
  • 随访中位180天复发率16%,复发者中10%需再住院。

核心结论

  • 乳糜心包炎多见于年轻患者,可导致心脏压塞等严重并发症,总体死亡率低但并发症需密切随访。

研究设计与样本

  • 系统综述,遵循PRISMA指南检索1946年至2021年5月文献,纳入95篇文献共98例患者。

主要发现

  • 患者平均年龄37±15岁,男性占55%,从症状出现到诊断时间中位5天(Q1 4.5,Q3 14),74%就诊时有症状。
  • 特发性乳糜心包炎占60%,心脏压塞占38%,94%病例需心包积液分析,淋巴管造影在59%患者中识别漏出部位。
  • 63%病例接受内科治疗(全肠外营养、中链甘油三酯或奥曲肽),32%进展至手术干预。
  • 中位随访180天(Q1 180,Q3 377),复发率16%,复发患者中10%再住院。

临床怎么用

  • 对年轻心包积液患者应警惕乳糜心包炎,需行心包积液分析及淋巴管造影定位漏出点。
  • 内科治疗可尝试全肠外营养、中链甘油三酯或奥曲肽,但需监测手术指征。
  • 治疗后应密切随访,关注复发及再住院风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Chylopericardium (CPE) is a rare condition associated with accumulation of triglyceride-rich chylous fluid in the pericardial cavity. Due to minimal information on CPE within the literature, we conducted a systematic review of all published CPE cases to understand its clinical characteristics, management and outcomes. METHODS: We performed a literature search and identified cases of patients with CPE from 1946 until May 2021 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We identified relevant articles for pooled analyses of clinical, diagnostic and outcome data. RESULTS: A total of 95 articles with 98 patients were identified. Patient demographics demonstrated male predominance (55%), with a mean age of 37±15 years. Time from symptom onset to diagnosis was 5 (Q1 4.5, Q3 14) days, with 74% of patients symptomatic on presentation. Idiopathic CPE (60%) was the most common aetiology. Cardiac tamponade secondary to CPE was seen in 38% of cases. Pericardial fluid analysis was required in 94% of cases. Lymphangiography identified the leakage site in 59% of patients. Medical therapy (total parenteral nutrition, medium-chain triglycerides or octreotide) was undertaken in 63% of cases. In our cohort, 32% progressed towards surgical intervention. During a median follow-up of 180 (Q1 180, Q3 377) days, CPE recurred in 16% of cases. Of the patients with recurrence, 10% were rehospitalised. CONCLUSION: CPE tends to develop in younger patients and may cause serious complications. Many patients fail medical therapy, thereby requiring surgical intervention. Although overall mortality is low, associated morbidities warrant close follow-up and possible reintervention and hospitalisations.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Verma B, Kumar A, Verma N, et al. Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review. Heart. 2023. PMID: 36702544. doi:10.1136/heartjnl-2022-321798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。